Mute Makes U.S. Debut in Select Walgreens and Duane Reade Stores

MELBOURNE, Australia, May 31, 2016 /PRNewswire/ -- Rhinomed LTD (ASX:RNO), an Australian nasal and respiratory technology company, is pleased to announce the U.S. debut of its Mute snoring and sleep technology. All four Mute packs (trial, small, medium and large) are now available in select Walgreens and Duane Reade stores across the U.S., including approximately 100 of the chain's locations throughout Manhattan, New York.

Made from ultra-soft medical grade polymers, Mute is a new over-the-counter technology developed by a team of specialists to alleviate the severity and incidence of snoring. Clinically proven to increase nasal air-flow during sleep by an average of 38 percent when compared to nasal strips, the discreet dilator fits snugly into the nose, gently and comfortably opening the airway. And the results speak for themselves.

In a 2014 user trial, 75 percent of users reported a reduction in the frequency and severity of their snoring when using Mute, while 57 percent saw an improvement in sleep quality. The Centers for Disease Control and Prevention (www.cdc.gov) estimates that more than 48 percent of Americans snore. According to IMS Health, global spending on sleep-related products increased 8.8 percent annually since 2008, with the U.S. market reaching $32 billion annually in 2012.

About Mute™Mute is a patented nasal respiratory technology that has been found to reduce the volume and frequency of snoring in 75 percent of users in (n=118 couples). Mute is easy to use, drug free and fits discreetly inside the nose. Mute is made from ultra soft polymers and works by stenting the nose and reducing nasal resistance. Mute encourages nasal breathing and reduces the need to open the mouth during sleep, factors critical to a reduction in snoring and better sleep quality. For more information and to locate a participating U.S. drugstore visit www.mutesnoring.com.

About Rhinomed Limited (ASX:RNO)Rhinomed Limited is a Melbourne, Australia based technology firm with a focus on nasal, respiratory and breathing management technologies. The company is developing and commercializing applications of its technology portfolio in the sport, sleep, wellbeing and drug delivery markets. The company has two products in market (Turbine for sports and exercise and Mute for snoring and better sleep) and is currently conducting a clinical trial of its new INPEAP technology targeting moderate sleep apnea. For more information, go to www.Rhinomed.global.